HIV-1 protease folding and the design of drugs which do not create resistance.
about
Multiple routes and milestones in the folding of HIV-1 protease monomerNMR and MD Studies Reveal That the Isolated Dengue NS3 Protease Is an Intrinsically Disordered Chymotrypsin Fold Which Absolutely Requests NS2B for Correct Folding and Functional DynamicsBioinformatics and Drug Discovery.Identification of broad-based HIV-1 protease inhibitors from combinatorial librariesEvolution under Drug Pressure Remodels the Folding Free-Energy Landscape of Mature HIV-1 ProteaseAnalysis and characterization of dimerization inhibition of a multi-drug-resistant human immunodeficiency virus type 1 protease using a novel size-exclusion chromatographic approachActive-site inhibitors modulate the dynamic properties of human monoacylglycerol lipase: a hydrogen exchange mass spectrometry studyThe molecular evolution of HIV-1 protease simulated at atomic detail.Thermodynamics of strongly allosteric inhibition: a model study of HIV-1 proteaseIdentification and characterization of folding inhibitors of hen egg lysozyme: An example of a new paradigm of drug design
P2860
Q28475755-498574AF-1CCF-4980-BED8-CE5E72024049Q28547136-A8B4C836-62B2-4F76-8351-6E2D2AF2E59CQ30395256-B90CE053-D009-4791-BBDB-7FC0B55CE4E1Q33589171-F7345E2D-886E-448C-99C0-DCDECB604AAFQ36999137-346DE214-787E-49FA-AAA8-13F89449BD45Q37357408-617A9E27-ACAE-49ED-BABE-750125263E7FQ37374110-C35AFD74-DAD8-48FD-929E-B9CD45D833FEQ51762113-3687B701-8CC3-4491-A865-E81C3883BFFEQ58882302-E1EC9CB4-B8B8-4D54-84FE-01D062F3487AQ58882307-540F6D6F-BFE3-4E7C-B955-8CA78A1B3CCC
P2860
HIV-1 protease folding and the design of drugs which do not create resistance.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HIV-1 protease folding and the design of drugs which do not create resistance.
@en
HIV-1 protease folding and the design of drugs which do not create resistance.
@nl
type
label
HIV-1 protease folding and the design of drugs which do not create resistance.
@en
HIV-1 protease folding and the design of drugs which do not create resistance.
@nl
prefLabel
HIV-1 protease folding and the design of drugs which do not create resistance.
@en
HIV-1 protease folding and the design of drugs which do not create resistance.
@nl
P1476
HIV-1 protease folding and the design of drugs which do not create resistance.
@en
P2093
P356
10.1016/J.SBI.2007.10.004
P50
P577
2007-12-21T00:00:00Z